Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 2,512.0 | 2,153.0 | 1,699.0 | 2,388.0 | 3,363.0 | 3,084.0 | 2,883.4 | 2,758.8 |
| Revenue growth | 16.7% | 26.7% | -28.9% | -29.0% | 9.0% | 7.0% | 4.5% | 54.4% |
| Cost of goods sold | 738.0 | 609.0 | 610.0 | 746.0 | 1,255.0 | 1,164.0 | 1,106.3 | 1,104.1 |
| Gross profit | 1,774.0 | 1,544.0 | 1,089.0 | 1,642.0 | 2,108.0 | 1,920.0 | 1,777.1 | 1,654.7 |
| Gross margin | 70.6% | 71.7% | 64.1% | 68.8% | 62.7% | 62.3% | 61.6% | 60.0% |
| Selling, general and administrative | 717.0 | 679.0 | 627.0 | 619.0 | 697.0 | 613.0 | 577.0 | 567.7 |
| Research and development | 218.0 | 190.0 | 148.0 | 166.0 | 202.0 | 184.0 | 204.8 | 183.9 |
| EBITA | 658.0 | 474.0 | 72.0 | 572.0 | 841.0 | 727.0 | 521.5 | 262.3 |
| EBITA margin | 26.2% | 22.0% | 4.2% | 24.0% | 25.0% | 23.6% | 18.1% | 9.5% |
| Amortization of intangibles | 239.0 | 197.0 | 207.0 | 257.0 | 297.0 | 260.0 | 251.9 | 245.5 |
| EBIT | 419.0 | 277.0 | -135.0 | 315.0 | 544.0 | 467.0 | 269.6 | 16.8 |
| EBIT margin | 16.7% | 12.9% | -7.9% | 13.2% | 16.2% | 15.1% | 9.4% | 0.6% |
| Pre-tax income | -163.0 | -294.0 | -804.0 | -377.0 | -339.0 | -227.0 | -478.7 | -1,694.2 |
| Income taxes | 13.0 | -318.0 | -3.0 | 3.0 | -13.0 | 15.0 | 125.0 | -299.9 |
| Tax rate | | 108.2% | 0.4% | | 3.8% | | | 17.7% |
| Earnings from continuing ops | -176.0 | 24.0 | -1,602.0 | -660.0 | -339.0 | -242.0 | -478.7 | -1,394.3 |
| Earnings from discontinued ops | 3,873.0 | 366.0 | 253.0 | 212.0 | | | | |
| Net income | 3,697.0 | 390.0 | -1,349.0 | -448.0 | -339.0 | -242.0 | -478.7 | -1,394.3 |
| Net margin | 147.2% | 18.1% | -79.4% | -18.8% | -10.1% | -7.8% | -16.6% | -50.5% |
| |
| Diluted EPS | ($1.85) | $0.24 | ($16.86) | ($7.10) | ($3.73) | ($2.72) | ($5.48) | ($16.23) |
| Shares outstanding (diluted) | 95.0 | 98.0 | 95.0 | 93.0 | 91.0 | 89.0 | 87.3 | 85.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|